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AMPK-SIRT1-PGC-1a SIGNALING REGULATES MITOCHONDRIAL
FUNCTION IN HUMAN ARTICULAR CHONDROCYTES
X. Zhao y, R. Terkeltaub y, M. Lotz z, R. Liu-Bryan y. yVAMC, UCSD, San
Diego, CA, USA; z The Scripps Res. Inst., San Diego, CA, USA
Purpose:Mitochondrial dysfunction in chondrocytes is associated with
osteoarthritis (OA), and impacts pathways implicated in cartilage
degradation, for example, by promoting oxidative stress and increasing
inﬂammatory cytokine-induced chondrocyte inﬂammation and matrix
catabolism. AMPK is a master regulator of cellular energy homeostasis.
We have previously reported that AMPK activity is reduced in human
knee OA articular chondrocytes. IL-1b, TNFa, and biomechanical injury
decrease AMPK activity in chondrocytes. In addition, AMPK pharma-
cologic activators suppress chondrocyte catabolic responses to inﬂam-
matory cytokines. Recent studies have demonstrated that SIRT1,
a nicotinamide adenine dinucleotide (NAD)-dependent protein deace-
tylase as another fuel-sensing molecule, also plays an important role in
cartilage matrix homeostasis. AMPK and SIRT1 share some common
target molecules involved in mitochondrial function including PGC-1a,
a master regulator of mitochondrial biogenesis. Therefore, we tested the
hypothesis that AMPK and SIRT1 coordinate to regulate mitochondrial
function in human articular chondrocytes, which contributes to regu-
lation of matrix metabolism.
Methods: Primary human knee chondrocytes treated with AMPK
pharmacologic activators AICAR (1 mM) and A-769662 (0.5 mM),
primary mouse chondrocytes isolated from femoral head cartilages of
AMPKa1 knockout (KO) and wild type (WT) mice, or primary human
knee chondrocytes transfected with SIRT1 or PGC-1a siRNA (Invitrogen)
were subjected to Western blot analyses for phosphorylation and
expression of AMPKa, expression of SIRT1 and PGC-1a. NAD/NADH ratio
and mitochondrial biogenesis such as expression of PGC-1a and mito-
chondrial transcriptional factor A (TFAM), a major transcriptional factor
governing mitochondrial DNA replication and transcription during
mitochondrial biogenesis) were assessed in chondrocytes stimulated
with AICAR and A-769662 by a NAD/NADH quantiﬁcation assay (Bio-
vision) and RT-PCR for mRNA expression of PGC-1a and TFAM,
respectively. The conditionedmedia of human knee chondrocytes in the
presence or absence of AICAR or A-769662, or the PGC-1a knockdown
chondrocytes stimulated with IL-1b (10 ng/ml) and TNFa (20 ng/ml)
was used for measuring nitric oxide (NO) generation and release of
MMP-3 and -13 by Griess reaction and ELISA, respectively.
Results: AMPK pharmacologic activators (AICAR or A-769662) pre-
vented oxidative stress by up-regulating expression of the anti-oxidant
enzymes SOD2 and catalase, effects dependent on PGC-1a. We observed
induction of NAD+/NADH ratio and SIRT1 expression in human chon-
drocytes stimulated with AICAR or A-769662. Conversely, inhibition of
SIRT1 expression was seen in AMPKa1 KO mouse chondrocytes.
However, knockdown of SIRT1 in human chondrocytes did not alter
phosphorylation and expression of AMPKa, but impaired PGC-1a
protein expression, suggesting that SIRT1 was downstream of AMPK but
upstream of PGC-1a. In addition, AICAR or A769662 promoted mito-
chondrial biogenesis, as evidenced by increased PGC-1a and TFAM
mRNA expression. These effects were linked to near complete inhibition
of catabolic responses, including >90% decreased release of NO and
MMP-3 andMMP-13 in chondrocytes (P< 0.01 for all) in response to IL-
1b and TNFa. Opposite results, with signiﬁcantly increased release of
NO, MMP-3 and MMP-13 (P<0.01) were observed in the PGC-1a
knockdown chondrocytes.
Conclusions: AMPK-SIRT1-PGC-1a signaling regulates mitochondrial
function by promoting mitochondrial biogenesis, decreasing oxidative
stress in chondrocytes. These effects contribute to attenuation, by
AMPK, of catabolic chondrocyte responses to inﬂammatory cytokines.
These ﬁndings provide a novel molecular mechanism by which phar-
macologic activation of AMPK has translational potential to inhibit
progression of cartilage degradation in OA.230
MANGANESE SUPEROXIDE DISMUTASE DEFICIENCY IN
CHONDROCYTES INDUCES MITOCHONDRIAL SUPEROXIDE
GENERATION LEADING TO IMPAIRED PROLIFERATION AND MATRIX
PRODUCTION, BUT NOT APOPTOSIS
M. Koike y,z, H. Nojiri z, Y. Saita z, D. Morikawa y,z, K. Kobayashi y,z,
K. Watanabe y, K. Kaneko z, T. Shimizu y. yDept. of Advanced AgingMed., Chiba Univ. Graduate Sch. of Med., Chiba, Japan; zDept. of
Orthopedics, Juntendo Univ. Graduate Sch. of Med., Tokyo, Japan
Purpose: Manganese superoxide dismutase (Sod2) is a major antioxi-
dant enzyme localized in the mitochondria, which diminish mito-
chondrial superoxide. It has been reported that mitochondrial SOD2
was signiﬁcantly down-regulated in the superﬁcial layer of OA cartilage
(Ruiz-Romero et al. Mol. Cell. Proteomics, 2009, Scott et al. Ann. Rheum.
Dis., 2010). However, it has been unclear how Sod2 insufﬁciency affected
physiological function of chondrocytes. Here, we investigated to clarify
the biological consequence of Sod2 deﬁciency and mitochondrial
superoxide generation in chondrocytes.
Methods: In order to investigate the effect of mitochondrial oxidative
stress, we generated Sod2-deﬁcient chondrocytes isolated from artic-
ular cartilage of newborn mice using tamoxifen-inducible cre-loxp
system (Rosa26-CreERT2tg/wt,Sod2ﬂox/ﬂox). Mitochondrial superoxide was
examined by dihydroethidium staining for ﬂow cytometry (FACS).
Cellular phenotypes of Sod2 deﬁciency in articular chondrocytes were
evaluated by cell number and proliferation via BrdU incorporation. To
investigate whether mitochondrial superoxide induces apoptosis,
apoptotic analyses were performed by annexin-V/PI staining and
western blot of caspase-3. To determine whether mitochondrial
superoxide leads to dysfunction in chondrocytes, expression of chon-
drocyte markers was performed by real time qPCR. Finally, we evalu-
ated extracellular matrix (ECM) in Sod2-deﬁcient chondrocytes using
alcian blue staining.
Results: Tamoxifen treatment decreased SOD2 protein at culture day 3,
and completely depleted SOD2 protein at culture day 6. Mitochondrial
superoxide generation was increased by 2.5-fold in Sod2-deﬁcient
chondrocytes compared with controls at culture day 6. There was no
signiﬁcant difference in cell number between Sod2-deﬁcient chon-
drocytes and controls at culture day 3, while total cell number of Sod2-
deﬁcient chondrocytes was signiﬁcantly decreased by 39% compared
with controls at culture day 6. However, we failed to ﬁnd increased
apoptotic cells. Cell proliferation in Sod2-deﬁcient chondrocytes was
suppressed by 35%, indicating that mitochondrial superoxide leads to
impaired cell proliferation without inducing apoptosis. In gene
expression analysis, anabolic genes including Sox9, Col2a1, and Acan
were signiﬁcantly down-regulated, while catabolic genes including
Mmp13 and Adamts5 were signiﬁcantly up-regulated. Moreover, alcian
blue staining of proteoglycans revealed a signiﬁcant decreased by 85%
in Sod2-diﬁcient chondrocytes at culture day 21.
Conclusions: These results revealed that Sod2 deﬁciency in chon-
drocytes induces mitochondrial superoxide generation leading to
impaired cell proliferation, but not apoptosis. Moreover, Sod2 deﬁciency
also decreased ECM production with imbalance between matrix
synthesis and degradation, suggesting that mitochondrial superoxide
plays a pivotal role in OA progression.231
INHIBITION OF COG5, A GENE FROM THE C7Q22 OSTEOARTHRITIS
SUSCEPTIBILITY LOCUS, INDUCES GLYCOSYLATION DEFECTS AND
AFFECTS CHONDROGENESIS AND OSTEOGENESIS BY DISTURBING
WNT SIGNALING
F. Cailotto, R.J. Lories;. KU Leuven, Leuven, Belgium
Purpose: Osteoarthritis (OA) is a highly disabling pathology of the
bone-cartilage unit, to which both patient-dependent (weight excess,
trauma/) and genetic factors contribute. Recently, a locus at chromo-
some 7q22 was linked to knee and hand OA by genome wide associa-
tion study. In this locus, the Conserved oligomeric Golgi complex
subunit (COG) 5 gene encodes a component of Golgi apparatus. Muta-
tions in humans are associated with mild congenital glycosylation
disorders, and COG5 expression is higher in 3D than in monolayer
cultures of articular chondrocytes. Here we investigated on the role of
COG5 during chondrogenesis and osteogenesis.
Methods: We used three independent stable clonal colonies of each,
controls (non-sliencing vector) and COG5 knocked-down cells (COG5-),
established in the chondrogenic ATDC5 and osteogenic MC3T3-E1 cell
lines. ATDC5 were cultured as high density micromasses (2x105 cells/
10 ml) to mimic the condensation step of developing cartilage. Chon-
drogenesis was induced by culturing cells for 14 days (D) in DMEM/F12
+ 5%FBS, supplemented with ITS (insulin, transferrin, sodium selenite).
On D14, cells were switched tomineralization medium (aMEM + 5%FBS,
supplemented with ITS, b-glycerophosphate (BGP) and ascorbic acid
